Andrew Ambrosy, MD

Start Year
2014

Education and Training

Fellowship
Cardiovascular Disease, Duke University

Residency
Stanford Hospital and Clinics

Medical School
Northwestern University Feinberg School of Medicine

College/university
Georgetown University

Career and Research Goals

I am currently a general cardiology fellow. My goal is to pursue a career in academic cardiology focused on outcomes and clinical trials in acute and chronic heart failure.

Publications

Gheorghiade, M, Pang, PS, Ambrosy, AP, Lan, G, Schmidt, P, Filippatos, G, Konstam, M, Swedberg, K, Cook, T, Traver, B, Maggioni, A, Burnett, J, Grinfeld, L, Udelson, J, and Zannad, F. "A comprehensive, longitudinal description of the in-hospital and post-discharge clinical, laboratory, and neurohormonal course of patients with heart failure who die or are re-hospitalized within 90 days: analysis from the EVEREST trial." Heart failure reviews 17, no. 3 (May 2012): 485-509.

PMID
21932146
Full Text

Ambrosy, AP, Vaduganathan, M, Huffman, MD, Khan, S, Kwasny, MJ, Fought, AJ, Maggioni, AP, Swedberg, K, Konstam, MA, Zannad, F, Gheorghiade, M, and EVEREST trial investigators, . "Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial." European journal of heart failure 14, no. 3 (March 2012): 302-311.

PMID
22357577
Full Text

Blair, JEA, Pang, PS, Schrier, RW, Metra, M, Traver, B, Cook, T, Campia, U, Ambrosy, A, Burnett, JC, Grinfeld, L, Maggioni, AP, Swedberg, K, Udelson, JE, Zannad, F, Konstam, MA, Gheorghiade, M, and EVEREST Investigators, . "Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial." European heart journal 32, no. 20 (October 2011): 2563-2572.

PMID
21785107
Full Text

Gheorghiade, M, Ambrosy, AP, Ferrandi, M, and Ferrari, P. "Combining SERCA2a activation and Na-K ATPase inhibition: a promising new approach to managing acute heart failure syndromes with low cardiac output." Discovery medicine 12, no. 63 (August 2011): 141-151. (Review)

PMID
21878191
Scholars@Duke

Ambrosy, A, and Gheorghiade, M. "Eplerenone reduces risk of cardiovascular death or hospitalisation in heart failure patients with reduced ejection fraction." Evidence-based medicine 16, no. 4 (August 2011): 121-122.

PMID
21558564
Full Text

Chioncel, O, Vinereanu, D, Datcu, M, Ionescu, DD, Capalneanu, R, Brukner, I, Dorobantu, M, Ambrosy, A, Macarie, C, and Gheorghiade, M. "The Romanian Acute Heart Failure Syndromes (RO-AHFS) registry." American heart journal 162, no. 1 (July 2011): 142-53.e1.

PMID
21742101
Full Text

Keeling, AN, Flaherty, JD, Davarpanah, AH, Ambrosy, A, Farrelly, CT, Harinstein, ME, Flamm, SL, Abecassis, MI, Skaro, AI, Carr, JC, and Gheorghiade, M. "Coronary multidetector computed tomographic angiography to evaluate coronary artery disease in liver transplant candidates: methods, feasibility and initial experience." Journal of cardiovascular medicine (Hagerstown, Md.) 12, no. 7 (July 2011): 460-468.

PMID
21610507
Full Text

Ambrosy, A, Goldsmith, SR, and Gheorghiade, M. "Tolvaptan for the treatment of heart failure: a review of the literature." Expert opinion on pharmacotherapy 12, no. 6 (April 2011): 961-976. (Review)

PMID
21401442
Full Text

Ambrosy, A, Wilcox, J, Nodari, S, and Gheorghiade, M. "Acute heart failure syndromes: assessment and reconstructing the heart." Journal of cardiovascular medicine (Hagerstown, Md.) 12, no. 4 (April 2011): 258-263.

PMID
21386686
Full Text

Gheorghiade, M, and Ambrosy, A. "Heart failure in 2010: one step forward, two steps back." Nature reviews. Cardiology 8, no. 2 (February 2011): 72-73. (Review)

PMID
21270845
Full Text

Pages